CoChat

Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Purpose: Originally developed in English, the Oxford Depression Questionnaire (ODQ) is a patient-reported scale specifically developed for assessing emotional blunting in people with major depressive disorder (MDD). We aimed to examine the reliability and validity of the Japanese version of the ODQ. Patients and methods: This was a prespecified analysis of a prospective, 24-week, multicenter, observational cohort study of employed Japanese outpatients with MDD initiating treatment with vortioxetine according to the Japanese label (JRCT1031210200). Participants were assessed using the Japanese version of the ODQ and other clinical rating scales at baseline and Weeks 8, 12 and 24. Results: One hundred and sixteen patients initiated vortioxetine and had ≥1 post-baseline visit. Directionally, the associations between ODQ scores and other clinical measures were as expected and demonstrated good concurrent validity. Factor analysis shows that the scale has a good fit for three factors. The Cronbach's α coefficient was 0.912, and the scale also showed good test-retest reliability with intraclass correlation coefficients for the ODQ total score and domains ranging between 0.69 and 0.82. ODQ scores had strong positive correlations with symptom severity assessed using the Montgomery and Åsberg Depression Rating Scale and were moderately correlated with work productivity, overall functioning, and quality of life scales. Conclusion: Data from this prospective analysis confirm that the Japanese version of the ODQ retains the good validity and reliability of the original English scale and is suitable for use in prospective studies wanting to capture treatment effects on emotional blunting in MDD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s428443

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Change from baseline in ODQ scores over 24 weeks.
Figure 1 Change from baseline in ODQ scores over 24 weeks.CC BY-NC · PubMed Central
Figure 2 Factor analysis (a) scree plot (b) factor loadings.
Figure 2 Factor analysis (a) scree plot (b) factor loadings.CC BY-NC · PubMed Central
Figure 3 Spearman Correlation “heat map” (a) ODQ score correlations with other measures (b) Change from baseline in ODQ correlations with change from baseline in other measures.
Figure 3 Spearman Correlation “heat map” (a) ODQ score correlations with other measures (b) Change from baseline in ODQ correlations with change from baseline in other measures.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Sansone, 2010, Psychiatry, 7, 14
  2. 1976, ECDEU Assessment Manual for Psychopharmacology

Cited by

See all 4

Metadata

Authors
Kato, M., Kikuchi, T., Watanabe, K., Sumiyoshi, T., Moriguchi, Y., Åström, D., & Christensen, M.
Affiliations
  • Kansai Medical University (JP)
  • Keio University (JP)
  • Kyorin University (JP)
  • National Center of Neurology and Psychiatry (JP)
  • Lundbeck (Denmark) (DK)
Corresponding author
Moriguchi, Yoshiya
Venue
Neuropsychiatric Disease and Treatment
Published
2023-11
Volume
Volume 19
Pages
2401-2412
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W4388495974
Cited by
3
References
42
Citations by year
2026: 2 · 2025: 1
FWCI
0.47
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Cell Science Research Foundation
  • Japan Research Foundation for Clinical Pharmacology
  • Japanese Society of Clinical Neuropsychopharmacology
  • Eisai
  • Meiji Seika Pharma
  • Astellas Pharma
  • Shionogi
  • Otsuka Pharmaceutical
  • SENSHIN Medical Research Foundation
  • Mitsubishi Tanabe Pharma Corporation
  • Ono Pharmaceutical
  • H. Lundbeck A/S
  • Japan Society for the Promotion of Science
  • Janssen Pharmaceuticals
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Keywords
Japanese version, major depressive disorder, emotional blunting, vortioxetine, patient-reported outcome measures, scale reliability, concurrent validity, factor structure, labor productivity, quality of life, outpatients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.